Measuring Upper Extremity Functional Movement With Accelerometry: FitBit® vs Actigraph®


To determine the criterion validity of the FitBit® Flex™ compared to the ActiGraph's Bluetooth® Smart wGT3X-BT wireless activity monitor, and contribute to the clinical utility of accelerometry measurement of UE movement.

Full Title of Study: “Measuring Upper Extremity Functional Movement With Accelerometry: FitBit vs Actigraph”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: May 1, 2016

Detailed Description

Participants will wear two different accelerometers (FitBit and Actigraph) to record normal, everyday movement. Data from each accelerometer will be compared to determine similarity.

Arms, Groups and Cohorts

  • Healthy adults
    • Healthy adults without any limitations in upper extremity movement or function.

Clinical Trial Outcome Measures

Primary Measures

  • Steps
    • Time Frame: 24 hours
    • Number of steps

Participating in This Clinical Trial

Inclusion Criteria

  • Healthy adults with no upper extremity limitations

Exclusion Criteria

  • Upper extremity limitations

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Rowe, Veronica, M.D.
  • Provider of Information About this Clinical Study
    • Principal Investigator: Veronica Rowe, Assistant Professor – Rowe, Veronica, M.D.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.